The clinical trials market size is projected to reach US$ 73.33 billion by 2031 from US$ 43.37 billion in 2023. The market is expected to register a CAGR of 6.8% during 2023–2031. AI-driven clinical trials is likely to act as a future trend in the market in the coming years.
𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲 @ https://www.theinsightpartners.com/sample/TIPRE00006203
The List of Companies
- IQVIA Holdings Inc
- Parexel International Corporation
- IXICO Plc
- Charles River Laboratories Inc
- ICON Plc
- WuXi AppTec Co Ltd
- SGS SA
- Syneos Health Inc
- SIRO Clinpharm Private Limited
- Thermo Fisher Scientific Inc
- Laboratory Corp of America Holdings
- CliniRx
- Caidya
- Oracle Corp
- Medpace
By Study Design
- Interventional Trials
- Expanded Access Trials
By Indications
- Autoimmune Diseases/Inflammation
- Pain Management
- Oncological Conditions
- Neurological Disorders
- Diabetes
- Obesity
- Metabolic Disorders
- Cardiovascular Diseases
By Phase Type
- Phase I
- Phase II
- Phase III
About US
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Food and Beverages, Consumers and Goods, Chemicals and Materials.
Contact US
Contact Person : Ankit Mathur
Phone : +1-646-491-9876
E-mail : sales@theinsightpartners.com
